Highly sensitive cancer diagnostic assay
A UK company has developed a novel mutation detection technology particularly suited for cancer diagnostic.
The diagnostic assay has significantly increased sensitivity and can reliably detect 10 copies of mutated DNA in a background of 10,000 normal copies. They are seeking companies or research institutions to license this technology, or to test or co-develop it towards new applications.
Closing date: 25/04/2015